CDSCO UID IMP/IVD/2019/000206_e5be32071055bb14c95b2353480b77c2_472badab56619f33a2bea107e4637461
HbA1c liquidirect HumaStar 600
Stedman Pharmaceuticals Pvt. Ltd.·Device Class Class B·India CDSCO
Registration details
- UID
- IMP/IVD/2019/000206_e5be32071055bb14c95b2353480b77c2_472badab56619f33a2bea107e4637461
- Device class
- Class B
- License holder
- Stedman Pharmaceuticals Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Immunoassay for the direct photometric determination of HbA1c in human venous blood with EDTA on HumaStar 300 SR and HumaStar 600
Other products from Stedman Pharmaceuticals Pvt. Ltd.
Products from the same license holder (10 products)
UREA liquiUV
Class B
TRANSFERRIN HumaStar 600
Class B
PHOSPHORUS liquirapid [HumaStar 300 SR, Humastar 600]
Class B
LDL CHOLESTEROL liquicolor HumaStar 600
Class B
URIC ACID liquicolor plus
Class B
SODIUM liquicolor [HumaStar 300SR, HumaStar 600]
Class B
HC5D DIFF LYSE
Class B
MAGNESIUM liquicolor
Class B
HDL CHOLESTEROL liquicolor [HumaStar 300SR, HumaStar 600]
Class B
UREA liquiUV HumaStar 600
Class B
About this record
HbA1c liquidirect HumaStar 600 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000206_e5be32071055bb14c95b2353480b77c2_472badab56619f33a2bea107e4637461. The license holder is Stedman Pharmaceuticals Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.